Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yunnan Panlong Yunhai Pharmaceutical Group is a prominent Chinese pharmaceutical company specializing in the research, development, and production of Traditional Chinese Medicine (TCM). Established in 1994 and headquartered in Kunming, the company is best known for its flagship product, Pai Du Yang Yan Capsules, which has become a household name in China for detoxification and skin health. The group operates an integrated business model that encompasses medicinal herb cultivation, advanced GMP-certified manufacturing, and an extensive domestic distribution network. Beyond its core pharmaceutical offerings, Panlong Yunhai has diversified into health supplements, functional foods, and personal care products leveraging Yunnan's rich biodiversity. The company is recognized as a major contributor to the modernization of TCM, focusing on standardized production and scientific validation of traditional formulas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yunnan Panlong Yunhai Pharmaceutical Group.